These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 3709867)
21. Effect of heparin and AMCA on coagulation and fibrinolysis in blood and lymph following massive haemorrhage in dogs. Leandoer L; Bergentz SE; Nilsson IM Acta Chir Scand; 1969; 135(1):1-6. PubMed ID: 5805939 [No Abstract] [Full Text] [Related]
22. [Effect of histamine and thymarin on blood coagulation and fibrinolysis in intact and thymectomized rats]. Kuznik BI; Pisarevskaia LI; Morozov VG; Khavinson VKh; Tsybikov NN Biull Eksp Biol Med; 1982 Sep; 94(9):27-9. PubMed ID: 7171817 [TBL] [Abstract][Full Text] [Related]
23. [Blood coagulation and fibrinolysis in rats with alloxan diabetes]. Aivazian AI; Petrishchev NN Patol Fiziol Eksp Ter; 1973; 17(2):83-5. PubMed ID: 4710432 [No Abstract] [Full Text] [Related]
24. [Experimental analysis of the pathophysiological significance of the "diabetogenic factor" present in the blood of animals with alloxan diabetes]. Baskakova GM; Kudriashov BA; Pytel' IuA Probl Endokrinol (Mosk); 1981; 27(4):42-5. PubMed ID: 7027248 [TBL] [Abstract][Full Text] [Related]
25. [Diabetogenic action of alloxan in short-term termination of the blood supply to the pancreas and spleen]. Ul'ianov AM; Tarasov IuA Nauchnye Doki Vyss Shkoly Biol Nauki; 1984; (8):48-51. PubMed ID: 6487685 [TBL] [Abstract][Full Text] [Related]
26. [Role of the thymus in regulating blood coagulation and fibrinolysis]. Kuznik BP; Tsybikov NN; Khavinson VKh; Morozov VG; Pisarevskaia LP Fiziol Zh SSSR Im I M Sechenova; 1982 Jan; 68(1):52-8. PubMed ID: 7060806 [TBL] [Abstract][Full Text] [Related]
27. [Animal sensitivity to the diabetogenic action of alloxan during cold adaptation]. Shorin IuP; Seliatitskaia VG; Nepomniashchikh GI; Pal'chikova NA; Khodova RR Biull Eksp Biol Med; 1984 Aug; 98(8):240-2. PubMed ID: 6466864 [TBL] [Abstract][Full Text] [Related]
28. [The significance of an increased protein and fat content in the food ration of rats for the development of stable alloxan diabetes]. Ul'ianov AM; Tarasov IuA Probl Endokrinol (Mosk); 1989; 35(6):78-81. PubMed ID: 2622891 [TBL] [Abstract][Full Text] [Related]
29. [Action of an adrenaline-heparin complex on the blood in vivo]. Liapina LA; Balakina TA Nauchnye Doki Vyss Shkoly Biol Nauki; 1974; 5():38-42. PubMed ID: 4275517 [No Abstract] [Full Text] [Related]
30. [Change in plasma esterase activity during stimulation of the "2d anticoagulation system"]. Baskova IP; Cherkesova DU; Orlova AS; Kudriashov BA Vopr Med Khim; 1974; 20(5):482-9. PubMed ID: 4456798 [No Abstract] [Full Text] [Related]
31. [C-peptide, diabetogenic factor and the blood anticoagulating system in patients with the insulin-dependent type of diabetes mellitus before and after heparin therapy]. Balabolkin MI; Kudriashov BA; Levitskaia ZI; Liapina LA; Ul'ianov AM Probl Endokrinol (Mosk); 1990; 36(1):25-8. PubMed ID: 2330356 [TBL] [Abstract][Full Text] [Related]
32. Anticoagulant modulation of blood cells and platelet reactivity by garlic oil in experimental diabetes mellitus. Ohaeri OC; Adoga GI Biosci Rep; 2006 Feb; 26(1):1-6. PubMed ID: 16779662 [TBL] [Abstract][Full Text] [Related]
33. [Prophylactic effect of vitamin A, neutralizing the development of experimental insulin-dependent diabetes in animals]. Kudriashov BA; Ul'ianov AM; Tarasov IuA Vopr Med Khim; 1993; 39(1):20-2. PubMed ID: 8498064 [TBL] [Abstract][Full Text] [Related]
34. [Protection of the islet apparatus in experimental alloxan diabetes]. Kudriashov BA; Pytel' IuA; Baskakova GM; Sokolova GA; Liapina LA Patol Fiziol Eksp Ter; 1982; (2):67-70. PubMed ID: 7045785 [No Abstract] [Full Text] [Related]
35. [Age-related characteristics of the manifestation of the diabetogenic factor in the blood of animals maintained on natural and atherogenic diets]. Kudriashov BA; Ul'ianov AM; Bazaz'ian GG; Pytel' IuA Probl Endokrinol (Mosk); 1984; 30(2):65-70. PubMed ID: 6718336 [TBL] [Abstract][Full Text] [Related]
37. [Functional state of the anticoagulation system during physiological aging of the organism]. Bazaz'ian GG; Sytina NP Nauchnye Doki Vyss Shkoly Biol Nauki; 1973; 114(6):29-33. PubMed ID: 4765677 [No Abstract] [Full Text] [Related]
38. L-arginine and polyamine administration protect beta-cells against alloxan diabetogenic effect in Sprague-Dawley rats. Méndez JD; Hernández Rde H Biomed Pharmacother; 2005 Jul; 59(6):283-9. PubMed ID: 15996850 [TBL] [Abstract][Full Text] [Related]
39. [Effect of hormonal contraceptives on the coagulation system with special reference to its inhibitors]. Misz M; Beck P; Flóra-Nagy M Orv Hetil; 1985 Oct; 126(43):2635-40. PubMed ID: 4058912 [TBL] [Abstract][Full Text] [Related]
40. [Isolation and various physico-chemical properties of diabetogenic factor from the blood of patients with diabetes]. Kudriashov BA; Liapina LA; Azieva LD Vopr Med Khim; 1989; 35(6):63-6. PubMed ID: 2629241 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]